CYCLOALKYL HETEROCYCLES FOR TREATING HEPATITIS C VIRUS
Compounds of Formula I are disclosed which inhibit hepatitis C NS5B RNA-dependent RNA polymerase and are useful for treating hepatitis C. Compositions and methods of using these compounds are also disclosed
Saved in:
Main Authors | , , , |
---|---|
Format | Patent |
Language | English French German |
Published |
16.02.2011
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!